URMC Research Network

Find People
Keyword
Last Name
 
More Search Options

Colin Poulter

Concepts (129)

Concepts are derived automatically from a person's publications.

Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of pubs Most recent pub Pubs by all authors Concept score Why?
Bone Neoplasms
7
1981
208
0.480
Why?
Radiotherapy Dosage
11
1969
202
0.350
Why?
Pelvic Neoplasms
3
1989
15
0.300
Why?
Palliative Care
7
1981
161
0.290
Why?
Neoplasm Recurrence, Local
4
1969
295
0.220
Why?
Colorectal Neoplasms
1
1992
143
0.190
Why?
Insurance, Health, Reimbursement
1
1990
35
0.180
Why?
Prostatic Neoplasms
3
1981
540
0.160
Why?
Clinical Trials as Topic
3
1985
685
0.150
Why?
Spinal Cord Compression
3
1968
17
0.140
Why?
Radiotherapy
5
1976
198
0.140
Why?
Radiotherapy, High-Energy
4
1981
24
0.100
Why?
Breast Neoplasms
4
1981
666
0.090
Why?
Humans
23
1968
37165
0.090
Why?
Lymphoma
2
1968
163
0.080
Why?
Combined Modality Therapy
4
1985
491
0.070
Why?
Aged
10
1969
7392
0.070
Why?
Pharyngeal Neoplasms
1
1976
7
0.070
Why?
Mouth Neoplasms
1
1976
34
0.070
Why?
Male
14
1968
20139
0.070
Why?
Middle Aged
10
1969
10013
0.070
Why?
Female
16
1969
20222
0.060
Why?
Rhenium
1
1993
1
0.060
Why?
Strontium Radioisotopes
1
1993
6
0.060
Why?
Phosphorus Radioisotopes
1
1993
24
0.060
Why?
Radioisotopes
1
1993
51
0.060
Why?
Aged, 80 and over
5
1988
2588
0.060
Why?
Neoplasms
3
1969
743
0.060
Why?
Radiation Injuries
1
1994
131
0.060
Why?
Lymphocyte Activation
1
1975
414
0.050
Why?
Prostate-Specific Antigen
1
1993
111
0.050
Why?
Brachytherapy
1
1993
109
0.050
Why?
Prostatectomy
1
1993
84
0.050
Why?
Liver Neoplasms
1
1993
155
0.050
Why?
Whole-Body Irradiation
1
1992
87
0.050
Why?
United States
2
1989
2847
0.050
Why?
American Cancer Society
1
1990
5
0.050
Why?
Hip Joint
1
1990
23
0.050
Why?
Drugs, Investigational
1
1990
8
0.050
Why?
Hodgkin Disease
2
1969
156
0.050
Why?
Ossification, Heterotopic
1
1990
20
0.050
Why?
Choristoma
1
1990
23
0.050
Why?
Hip Prosthesis
1
1990
40
0.050
Why?
Adult
8
1968
11572
0.050
Why?
Tibia
1
1990
73
0.050
Why?
Patient Advocacy
1
1990
50
0.050
Why?
Prognosis
5
1969
1078
0.040
Why?
Brain Neoplasms
1
1993
282
0.040
Why?
Mastectomy, Segmental
1
1989
25
0.040
Why?
Lung Neoplasms
4
1969
435
0.040
Why?
Multicenter Studies as Topic
1
1989
127
0.040
Why?
Mastectomy
1
1988
42
0.040
Why?
Neoplasm Metastasis
2
1969
229
0.040
Why?
Patient Education as Topic
1
1990
227
0.040
Why?
Ascitic Fluid
1
1988
22
0.040
Why?
Retrospective Studies
4
1976
2302
0.040
Why?
Uterine Neoplasms
1
1988
105
0.040
Why?
Bone and Bones
1
1990
360
0.040
Why?
Adenocarcinoma
2
1984
483
0.040
Why?
Pilot Projects
2
1985
446
0.020
Why?
Age Factors
2
1988
1152
0.020
Why?
Doxorubicin
1
1976
105
0.020
Why?
Premedication
2
1985
21
0.020
Why?
Lymphatic Metastasis
2
1984
153
0.020
Why?
Radiation Effects
1
1975
15
0.020
Why?
Mitogens
1
1975
36
0.020
Why?
Carcinoma, Small Cell
2
1984
33
0.020
Why?
Neoplasm, Residual
1
1994
21
0.020
Why?
Mitosis
1
1975
101
0.020
Why?
Adolescent
2
1993
5044
0.010
Why?
Receptors, Estrogen
1
1994
180
0.010
Why?
Sex Factors
1
1994
613
0.010
Why?
Incidence
1
1994
682
0.010
Why?
Head and Neck Neoplasms
2
1969
84
0.010
Why?
Multivariate Analysis
1
1993
548
0.010
Why?
Survival Rate
1
1993
619
0.010
Why?
T-Lymphocytes
1
1975
564
0.010
Why?
Neoplasms, Experimental
2
1968
149
0.010
Why?
Neurologic Manifestations
1
1969
7
0.010
Why?
Cerebrospinal Fluid Proteins
1
1969
9
0.010
Why?
Myelography
1
1969
14
0.010
Why?
Laminectomy
1
1969
11
0.010
Why?
Prosthesis Design
1
1990
64
0.010
Why?
Radionuclide Imaging
1
1969
51
0.010
Why?
Prospective Studies
1
1994
1696
0.010
Why?
Lymphography
1
1969
9
0.010
Why?
Technology, Radiologic
1
1969
17
0.010
Why?
Parotid Neoplasms
1
1969
12
0.010
Why?
Mediastinal Neoplasms
1
1969
21
0.010
Why?
Methods
1
1969
225
0.010
Why?
Diaphragm
1
1969
27
0.010
Why?
Follow-Up Studies
1
1994
1889
0.010
Why?
Angiography
1
1969
91
0.010
Why?
Radiation-Sensitizing Agents
2
1969
74
0.010
Why?
Esthetics
1
1988
26
0.010
Why?
Rabbits
1
1990
720
0.010
Why?
Respiration
1
1969
181
0.010
Why?
Cells, Cultured
1
1975
2589
0.010
Why?
Randomized Controlled Trials as Topic
1
1990
415
0.010
Why?
Lymph Nodes
1
1969
215
0.010
Why?
Lymphoma, Large B-Cell, Diffuse
1
1968
80
0.010
Why?
Carcinoma, Squamous Cell
2
1969
238
0.010
Why?
Gastrointestinal Diseases
1
1986
35
0.010
Why?
Time Factors
2
1981
3234
0.010
Why?
Hematologic Diseases
1
1986
40
0.010
Why?
Neoplasm Staging
1
1988
354
0.010
Why?
Narcotics
1
1986
45
0.010
Why?
Oxygen
1
1969
495
0.010
Why?
Amifostine
1
1985
28
0.010
Why?
Pancoast Syndrome
1
1984
1
0.010
Why?
Length of Stay
1
1986
295
0.010
Why?
Carcinoma, Bronchogenic
1
1984
21
0.010
Why?
Animals
3
1968
16416
0.010
Why?
Pain
1
1986
392
0.010
Why?
Antineoplastic Combined Chemotherapy Protocols
1
1985
436
0.010
Why?
Dose-Response Relationship, Radiation
1
1981
216
0.010
Why?
Child
1
1969
4342
0.010
Why?
Rats
1
1968
4389
0.010
Why?
Antineoplastic Agents
1
1985
628
0.010
Why?
Heart Injuries
1
1976
13
0.000
Why?
Mouth Mucosa
1
1976
44
0.000
Why?
Lung Injury
1
1976
77
0.000
Why?
Esophagus
1
1976
119
0.000
Why?
Drug Therapy, Combination
1
1976
397
0.000
Why?
Skin
1
1976
384
0.000
Why?
Hyperbaric Oxygenation
1
1969
7
0.000
Why?
Computers
1
1969
83
0.000
Why?
Head
1
1969
77
0.000
Why?
Models, Theoretical
1
1969
194
0.000
Why?

Visualizations


Poulter's Networks

Concepts
_
Co-Authors
_
Similar People
_
Same Department